[1] | Fishbain, J., and A.Y. Peleg, 2010. Treatment of acinetobacter infections. Clin Infect Dis., 51 (1): 79-84. |
|
[2] | Peleg, A.Y., H. Seifert, and D.L. Paterson, 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev., 21: 538-582. |
|
[3] | Maragakis, L.L., and T.M. Perl, 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis., 46:1254-1263. |
|
[4] | Naved, S.A., S. Siddiqui, and F.H. Khan, 2011. APACHE-II Score correlation with mortality and length of stay in an intensive care unit. J Coll Physicians Surg Pak., 21 (1): 4-8. |
|
[5] | Clinical and Laboratory Standard Institute, 2014. M100-S24 Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. http://ncipd.org/control/images/NCIPD_docs/CLSI_M100-S24.pdf (Accessed on October 16, 2015). |
|
[6] | Manchanda, V., S. Sanchaita, and N.P. Singh, 2010. Multidrug resistant acinetobacter. J Glob Infect Dis., 2(3): 291-304. |
|
[7] | Sunenshine, R.H., M.-O. Wright, L.L. Maragakis, A.D. Harris, and X. Song et al., 2007. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis., 13(1): 97-103. |
|
[8] | Anunnatsiri, S., and P. Tonsawa, 2011. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Southeast Asian J Trop Med Public Health., 42(3): 693-703. |
|
[9] | Ntusi, N.B.A., M. Badri, H. Khalfey, A. Whitelaw, and S. Oliver et al., 2012. ICU-associated Acinetobacter baumannii colonization/Infection in a high HIV pprevalence resource-poor setting. PLoS ONE 7(12): e52452. |
|
[10] | Jung, J.Y., M.S. Park, S.E. Kim, B.H. Park, J. Y. Son, and E.Y. Kim et al., 2010. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis., 10: 228. |
|
[11] | Emine, A.L.P., M. Yerer, S. Kocagö, G. Metan, and D. Esel et al., 2009. The risk factors and spread of multidrug-resistant Acinetobacter baumannii in intubated patients in a medical intensive care unit. Turk J Med Sci. May., 39 (5): 761-769. |
|
[12] | McGee S., 2002. Simplifying likelihood ratios. J Gen Intern Med., 17(8): 647-650. |
|
[13] | Lee, Y.T., S.C. Kuo, S.P. Yang, Y.T. Lin, and F.C. Tseng et al., 2012. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis., 55 (2): 209-215. |
|
[14] | Dent L.L., D.R. Marshall, S. Pratap, and R.B. Hulette, 2010. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis., 10: 196. |
|
[15] | Paterson D.L., 2006. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis., 43 (S2): S43-S48. |
|
[16] | Magiorakos, A.-P., A. Srivasan, R.B. Carey, Y. Carmeli, and M.E. Falagas et al., 2011. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect., 18: 268-281. |
|
[17] | Tjoa. E., L.H. Moehario, A. Rukmana, and R. Rohsiswatmo, 2013. Acinetobacter baumannii: Role in blood stream infection in neonatal unit, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Int J Microbiol., 180763. |
|
[18] | Mahajan. G., S. Sheemar, S. Chopra, J. Kaur, and D. Chowdhary et al., 2011. Carbapenem resistance and phenotypic detection of carbapenemases in clinical isolates of Acinetobacter baumannii. Indian J Med Sci., 65 (1):18-25. |
|
[19] | Lemos, E.V., F.P. de la Hoz, T.R. Einarson, W.F. McGhan, and E. Quevedo et al., 2014. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect., 20: 416-423. |
|